Effects of Roflumilast in COPD Patients Receiving Inhaled Corticosteroid/Long-Acting Β2-Agonist Fixed-Dose Combination: RE2SPOND Rationale and Study Design
International Journal of COPD - New Zealand
doi 10.2147/copd.s109661
Full Text
Open PDFAbstract
Available in full text
Categories
Date
August 1, 2016
Authors
Publisher
Informa UK Limited